Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Suzhou Ribo Life Science Co., Ltd. (6938)
Market Closed
12 Aug, 08:00
HKEX
All
(1)
HK
(1)
HKEX
Primary
53.
65
HKD
+0.35
+0.6567%
HKD
9.51B
Market Cap
-
P/E Ratio
-
Div Yield
119,497
Volume
-
Eps
53.3
HKD
Previous Close
Watching
Watch
Add Transaction
Day Range
52.05
54.35
Year Range
43.6
95.8
Want to track
6938
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
Suzhou Ribo Life Science Co., Ltd. (6938) Statistics
Valuation metrics
Market Cap
9.51B
Enterprise value
8.77B
Trailing P/E (ttm)
-
Forward P/E
-0.34
PEG ratio
-0.34
Price/Sales (ttm)
64.03
Price/Book (mrq)
-
Enterprise Value/Revenue
51.02
Enterprise Value/EBITDA
-31.35
Overview
Shares outstanding
161.69M
Float
79.79M
Shares short
-
% Held by insiders
0.54%
% Held by institutions
0.25%
Average volume (10 days)
153.61K
Average volume (90 days)
202.46K
Price summary
52-Week low
43.6
52-Week high
95.8
Beta
-
50-Day moving average
61.18
200-Day moving average
64.88
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
-1.87%
Operating margin
-4.22%
Operational effectiveness
Return on assets
-0.23%
Return on equity
-10.39%
Income Statement
Revenue (ttm)
171.96M
Revenue per share (ttm)
1.13
Quarterly revenue growth (yoy)
-0.41%
Gross profit (ttm)
140.95M
EBITDA
-279.85M
Net income to common (ttm)
-321.96M
Diluted EPS (ttm)
-1.99
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
472.81M
Total cash per share (mrq)
3.04
Total debt (mrq)
636.93M
Total Debt/Equity (mrq)
2,054.49
Current ratio (mrq)
0.86%
Book value per share (mrq)
-0.81
Cash Flow
Cash flow statement
-325.01M
Levered free cash flow (LFCF)
-138.27M